BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tinsley SL, Allen-Petersen BL. PP2A and cancer epigenetics: a therapeutic opportunity waiting to happen. NAR Cancer 2022;4:zcac002. [PMID: 35118387 DOI: 10.1093/narcan/zcac002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Aakula A, Sharma M, Tabaro F, Nätkin R, Kamila J, Honkanen H, Schapira M, Arrowsmith C, Nykter M, Westermarck J. RAS and PP2A activities converge on epigenetic gene regulation. Life Sci Alliance 2023;6. [PMID: 36858798 DOI: 10.26508/lsa.202301928] [Reference Citation Analysis]
2 Randhawa PK, Rajakumar A, Futuro de Lima IB, Gupta MK. Eugenol attenuates ischemia-mediated oxidative stress in cardiomyocytes via acetylation of histone at H3K27. Free Radic Biol Med 2023;194:326-36. [PMID: 36526244 DOI: 10.1016/j.freeradbiomed.2022.12.007] [Reference Citation Analysis]
3 Nussinov R, Tsai CJ, Jang H. A New View of Activating Mutations in Cancer. Cancer Res 2022;82:4114-23. [PMID: 36069825 DOI: 10.1158/0008-5472.CAN-22-2125] [Reference Citation Analysis]
4 Babar Q, Saeed A, Tabish TA, Pricl S, Townley H, Thorat N. Novel epigenetic therapeutic strategies and targets in cancer. Biochim Biophys Acta Mol Basis Dis 2022;1868:166552. [PMID: 36126898 DOI: 10.1016/j.bbadis.2022.166552] [Reference Citation Analysis]
5 Poudel G, Tolland MG, Hughes TP, Pagani IS. Mechanisms of Resistance and Implications for Treatment Strategies in Chronic Myeloid Leukaemia. Cancers (Basel) 2022;14:3300. [PMID: 35884363 DOI: 10.3390/cancers14143300] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Aakula A, Sharma M, Tabaro F, Honkanen H, Schapira M, Arrowsmith C, Nykter M, Westermarck J. RAS and PP2A activities converge on epigenetic gene regulation.. [DOI: 10.1101/2022.05.11.491459] [Reference Citation Analysis]
7 Yang D, Dickerhoff J, Dynan WS. Editorial: NAR Cancer and epigenetics and cancer. NAR Cancer 2022;4:zcac003. [PMID: 35252865 DOI: 10.1093/narcan/zcac003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]